Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2016

Open Access 01-12-2016 | Research article

The efficacy of topical tranexamic acid in total hip arthroplasty: a meta-analysis

Authors: Shubiao Chen, Kezhou Wu, Gengbin Kong, Weili Feng, Zhihua Deng, Hu Wang

Published in: BMC Musculoskeletal Disorders | Issue 1/2016

Login to get access

Abstracts

Background

Topical tranexamic acid (TXA) has been shown to be effective in reducing blood loss and the need for transfusion after total knee arthroplasty. However, the effectiveness of topical TXA use in total hip arthroplasty (THA) still remains unclear. The purpose of this meta-analysis is to examine the safety and efficacy of topical use of TXA following THA.
Hypothesis: Topical TXA reduces blood loss and transfusion rates without increasing risk of deep vein thrombosis in patients with THA.

Methods

An electronic literature search of PubMed, Embase, the Cochrane Library, Web of Science and Chinese Biomedical Database was performed, to identify studies published before February 2015. All randomized controlled trials and cohort studies evaluating the efficacy of topical TXA during THA were included. Two independent authors identified the eligible studies, assessed their methodological quality, and extracted data. The data were using fixed-effects or random-effects models with (standard) mean differences and risk ratios for continuous and dichotomous variables, respectively. Data were analysed using RevMan 5.3 software.

Results

Fourteen studies encompassing 2594 patients met the inclusion criteria for our meta-analysis. Our meta-analysis indicated that when compared with the placebo group, topical use of TXA significantly reduced total blood loss (MD = −297.65 ml, 95 % CI −371.68 ml, 116.08 ml; P < 0.01), drainage loss (MD = −164.68 ml, 95 % CI −236.63 ml, −92.73 ml; P < 0.01), transfusion rate (RR = 0.26, 95 % CI 0.17, 0.40; P < 0.01) and with less of a drop in haemoglobin level (SMD = −0.66, 95 % CI −0.91, −0.41; P < 0.01) after primary THA. No significant difference in length of hospital stay (MD = −0.40, 95 % CI −0.91, 0.11; P = 0.14), deep vein thrombosis (RR = 1.19, 95 % CI 0.40, 3.57; P = 0.16) and pulmonary embolism (RR = 1.11, 95 % CI 0.11, 10.81; P = 0.21) among the study groups.

Conclusions

Topical TXA could significantly reduce total blood loss, drainage loss, transfusion rates and decrease haemoglobin level following THA, without increasing risk of venous thromboembolisms.
Literature
1.
go back to reference Iorio R, Robb WJ, Healy WL, Berry DJ, Hozack WJ, Kyle RF, et al. Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the United States: preparing for an epidemic. J Bone Joint Surg Am. 2008;90(7):1598–605.CrossRefPubMed Iorio R, Robb WJ, Healy WL, Berry DJ, Hozack WJ, Kyle RF, et al. Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the United States: preparing for an epidemic. J Bone Joint Surg Am. 2008;90(7):1598–605.CrossRefPubMed
2.
go back to reference Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780–5.CrossRefPubMed Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780–5.CrossRefPubMed
3.
go back to reference Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003;43(4):459–69.CrossRefPubMed Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003;43(4):459–69.CrossRefPubMed
4.
go back to reference Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999;81(1):2–10.PubMed Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999;81(1):2–10.PubMed
6.
go back to reference Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009;113(15):3406–17.CrossRefPubMed Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009;113(15):3406–17.CrossRefPubMed
7.
go back to reference Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al. Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med. 2012;157(1):49–58.CrossRefPubMed Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al. Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med. 2012;157(1):49–58.CrossRefPubMed
8.
go back to reference Watts CD, Pagnano MW. Minimising blood loss and transfusion in contemporary hip and knee arthroplasty. J Bone Joint Surg (Br). 2012;94(11 Suppl A):8–10.CrossRef Watts CD, Pagnano MW. Minimising blood loss and transfusion in contemporary hip and knee arthroplasty. J Bone Joint Surg (Br). 2012;94(11 Suppl A):8–10.CrossRef
9.
go back to reference Eubanks JD. Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg. 2010;18(3):132–8.PubMed Eubanks JD. Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg. 2010;18(3):132–8.PubMed
10.
go back to reference Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ. 2014;349:g4829.PubMedCentralCrossRefPubMed Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ. 2014;349:g4829.PubMedCentralCrossRefPubMed
11.
go back to reference Clave A, Fazilleau F, Dumser D, Lacroix J. Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: A case–control study in 70 patients. Orthop Traumatol Surg Res. 2012;98(5):484–90.CrossRefPubMed Clave A, Fazilleau F, Dumser D, Lacroix J. Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: A case–control study in 70 patients. Orthop Traumatol Surg Res. 2012;98(5):484–90.CrossRefPubMed
12.
go back to reference Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg (Br). 2011;93(1):39–46.CrossRef Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg (Br). 2011;93(1):39–46.CrossRef
13.
go back to reference Zhou XD, Tao LJ, Li J, Wu LD. Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials. Arch Orthop Trauma Surg. 2013;133(7):1017–27.CrossRefPubMed Zhou XD, Tao LJ, Li J, Wu LD. Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials. Arch Orthop Trauma Surg. 2013;133(7):1017–27.CrossRefPubMed
14.
go back to reference Chang CH, Chang Y, Chen DW, Ueng SW, Lee MS. Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty. Clin Orthop Relat Res. 2014;472(5):1552–7.PubMedCentralCrossRefPubMed Chang CH, Chang Y, Chen DW, Ueng SW, Lee MS. Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty. Clin Orthop Relat Res. 2014;472(5):1552–7.PubMedCentralCrossRefPubMed
15.
go back to reference Fan FC, Gui BJ. Tranexamic acid injection through articular cavity and discontinuous clip pipe after total hip arthroplasty: changes in bleeding amount. Chin J Tissue Eng Res. 2014;18(40):6397–402. Fan FC, Gui BJ. Tranexamic acid injection through articular cavity and discontinuous clip pipe after total hip arthroplasty: changes in bleeding amount. Chin J Tissue Eng Res. 2014;18(40):6397–402.
16.
go back to reference Gilbody J, Dhotar HS, Perruccio AV, Davey JR. Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty. J Arthroplasty. 2014;29(4):681–4.CrossRefPubMed Gilbody J, Dhotar HS, Perruccio AV, Davey JR. Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty. J Arthroplasty. 2014;29(4):681–4.CrossRefPubMed
17.
go back to reference Konig G, Hamlin BR, Waters JH. Topical Tranexamic Acid Reduces Blood Loss and Transfusion Rates in Total Hip and Total Knee Arthroplasty. J Arthroplasty. 2013;28(9):1473–6.CrossRefPubMed Konig G, Hamlin BR, Waters JH. Topical Tranexamic Acid Reduces Blood Loss and Transfusion Rates in Total Hip and Total Knee Arthroplasty. J Arthroplasty. 2013;28(9):1473–6.CrossRefPubMed
18.
go back to reference Van Elst CE, Vanbiervliet J, Simon JP, et al. The Effect of Topical Application of Tranexamic Acid in Total Hip Arthroplasty through the Direct Anterior Approach. American Academy of Orthopaedic Surgeons Annual Meeting, March, 2013. Van Elst CE, Vanbiervliet J, Simon JP, et al. The Effect of Topical Application of Tranexamic Acid in Total Hip Arthroplasty through the Direct Anterior Approach. American Academy of Orthopaedic Surgeons Annual Meeting, March, 2013.
19.
go back to reference Wei W, Wei B. Comparison of topical and intravenous tranexamic Acid on blood loss and transfusion rates in total hip arthroplasty. J Arthroplasty. 2014;29(11):2113–6.CrossRefPubMed Wei W, Wei B. Comparison of topical and intravenous tranexamic Acid on blood loss and transfusion rates in total hip arthroplasty. J Arthroplasty. 2014;29(11):2113–6.CrossRefPubMed
20.
go back to reference Yin H, Wang DW, Ma WP, Xing DL, W ZF. The efficacy and safety of tranexamic acid for reducing blood loss in primary total hip arthroplasty. Chin J Joint Surg. 2014;8(5):669–72. Yin H, Wang DW, Ma WP, Xing DL, W ZF. The efficacy and safety of tranexamic acid for reducing blood loss in primary total hip arthroplasty. Chin J Joint Surg. 2014;8(5):669–72.
21.
go back to reference Yue C, Kang P, Yang P, Xie J, Pei F. Topical application of tranexamic Acid in primary total hip arthroplasty: a randomized double-blind controlled trial. J Arthroplasty. 2014;29(12):2452–6.CrossRefPubMed Yue C, Kang P, Yang P, Xie J, Pei F. Topical application of tranexamic Acid in primary total hip arthroplasty: a randomized double-blind controlled trial. J Arthroplasty. 2014;29(12):2452–6.CrossRefPubMed
22.
go back to reference Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). J Bone Joint Surg Am. 2013;95(21):1969–74.CrossRefPubMed Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). J Bone Joint Surg Am. 2013;95(21):1969–74.CrossRefPubMed
23.
go back to reference Ding M, Qi W, Liu FG, Xu Z, Gu YF, L ML. Efficacy of topical tranexamic acid in total hip arthroplasty. J Med Postgra. 2014;27(8):833–5. Ding M, Qi W, Liu FG, Xu Z, Gu YF, L ML. Efficacy of topical tranexamic acid in total hip arthroplasty. J Med Postgra. 2014;27(8):833–5.
24.
go back to reference Bagsby DT, Hur J. Effect of Intra-articular Injection of Tranexamic Acid on Postoperative Hemoglobin in Total Hip Arthroplasty. Orthopedics. 2014;37(6):E557–62.CrossRefPubMed Bagsby DT, Hur J. Effect of Intra-articular Injection of Tranexamic Acid on Postoperative Hemoglobin in Total Hip Arthroplasty. Orthopedics. 2014;37(6):E557–62.CrossRefPubMed
25.
go back to reference Martin JG, Cassatt KB, Kincaid-Cinnamon KA, Westendorf DS, Garton AS, Lemke JH. Topical Administration of Tranexamic Acid in Primary Total Hip and Total Knee Arthroplasty. J Arthroplasty. 2014;29(5):889–94.CrossRefPubMed Martin JG, Cassatt KB, Kincaid-Cinnamon KA, Westendorf DS, Garton AS, Lemke JH. Topical Administration of Tranexamic Acid in Primary Total Hip and Total Knee Arthroplasty. J Arthroplasty. 2014;29(5):889–94.CrossRefPubMed
26.
go back to reference Machin JT, Batta V, Soler JA, Sivagaganam K, Kalairajah Y. Comparison of intra-operative regimes of tranexamic acid administration in primary total hip replacement. Acta Orthop Belg. 2014;80(2):228–33.PubMed Machin JT, Batta V, Soler JA, Sivagaganam K, Kalairajah Y. Comparison of intra-operative regimes of tranexamic acid administration in primary total hip replacement. Acta Orthop Belg. 2014;80(2):228–33.PubMed
27.
go back to reference Wind TC, Barfield WR, Moskal JT. The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty. J Arthroplasty. 2014;29(2):387–9.CrossRefPubMed Wind TC, Barfield WR, Moskal JT. The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty. J Arthroplasty. 2014;29(2):387–9.CrossRefPubMed
28.
go back to reference Higgins. JPT, Green. S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available at: www.cochrane-handbook.org. Accessed February 2, 2012 Higgins. JPT, Green. S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available at: www.​cochrane-handbook.​org. Accessed February 2, 2012
29.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12.CrossRefPubMed Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12.CrossRefPubMed
31.
32.
go back to reference Wong J, Abrishami A, El Beheiry H, Mahomed NN, Davey JR, Gandhi R, et al. Topical Application of Tranexamic Acid Reduces Postoperative Blood Loss in Total Knee Arthroplasty A Randomized, Controlled Trial. J Bone Joint Surg Am. 2010;92A(15):2503–13. Wong J, Abrishami A, El Beheiry H, Mahomed NN, Davey JR, Gandhi R, et al. Topical Application of Tranexamic Acid Reduces Postoperative Blood Loss in Total Knee Arthroplasty A Randomized, Controlled Trial. J Bone Joint Surg Am. 2010;92A(15):2503–13.
33.
go back to reference Alshryda S, Sukeik M, Sarda P, Blenkinsopp J, Haddad FS, Mason JM. A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J. 2014;96-B(8):1005–15.CrossRefPubMed Alshryda S, Sukeik M, Sarda P, Blenkinsopp J, Haddad FS, Mason JM. A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J. 2014;96-B(8):1005–15.CrossRefPubMed
Metadata
Title
The efficacy of topical tranexamic acid in total hip arthroplasty: a meta-analysis
Authors
Shubiao Chen
Kezhou Wu
Gengbin Kong
Weili Feng
Zhihua Deng
Hu Wang
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2016
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-016-0923-0

Other articles of this Issue 1/2016

BMC Musculoskeletal Disorders 1/2016 Go to the issue